Author

A. Obregon-Henao

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. A. Bauman· 1 shared A. Fox· 1 shared B. K. Podell· 1 shared B. Karger· 1 shared B. R. Karger· 1 shared G. T. Robertson· 1 shared I. K. Ragan· 1 shared J. Reid· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. A. Bauman

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Use of Multiple Pharmacodynamic Measures to Deconstruct the Nix-TB Regimen in a Short-Course Murine Model of Tuberculosis

M. A. Lyons, A. Obregon-Henao, M. E. Ramey, A. A. Bauman, S. Pauly, K. Rossmassler, J. Reid, B. Karger, N. D. Walter, G. T. Robertson

The paper evaluates the Nix-TB regimen in a murine TB model using pharmacodynamic markers to assess drug contributions and interactions.

bioRxiv · Nov 8, 2023Pharmacology & Toxicology

A Whole Virion Vaccine for COVID-19 Produced Via a Novel Inactivation Method: Results from Animal Challenge Model Studies

I. K. Ragan, L. M. Hartson, T. S. Dutt, A. Obregon-Henao, R. M. Maison, P. Gordy, A. Fox, B. R. Karger, S. T. Cross, M. L. Kapuscinski, S. K. Cooper, B. K. Podell, M. D. Stenglein, R. A. Bowen, M. Henao-Tamayo, R. Goodrich

This paper evaluates a novel inactivated whole virion COVID-19 vaccine (SolaVAX) in hamsters, showing its ability to induce neutralizing antibodies and protect against SARS-CoV-2 infection.

bioRxiv · Nov 13, 2020Immunology